• Monday, Oct 18, 2021
  • Last Update : 07:35 pm

J&J finds problem with Covid vaccine batch

  • Published at 03:07 pm April 1st, 2021
J&J’s vaccine
File photo: Vials with a sticker reading, 'Covid-19 / Coronavirus vaccine / Injection only' and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020 Reuters

The New York Times reported that about 15m doses were ruined

Johnson & Johnson said on Wednesday that it had found a problem with a batch of the drug substance for its Covid-19 vaccine being produced by Emergent BioSolutions and said the batch did not advance to the final fill-and-finish stage.

J&J did not say how many vaccines doses the batch would have produced. However, The New York Times reported that about 15 million doses were ruined, without citing a source.

The Times said that workers had conflated ingredients for the J&J vaccine and a coronavirus vaccine developed by AstraZeneca Plc, which is produced at the same plant, several weeks ago.

The manufacturing misstep follows manufacturing issues at J&J, which is seen as one of the most important Covid-19 vaccines globally, because its vaccine is a single dose and requires relatively little special handling. J&J said manufacturing was on track.

J&J did not directly respond to a question about the number of doses ruined, only responding with a statement saying that the batch being produced at Emergent BioSolutions' site in Baltimore did not meet quality standards and did not advance to the fill-and-finish stage, which is handled by another company.

J&J said the problem at the Emergent BioSolutions plant, which is not yet authorized to produce the drug substance for the vaccine, was identified and addressed with Emergent and shared with the US Food and Drug Administration. J&J said it was sending more people to supervise manufacturing at the plant.

News of the setback comes at a time when the Biden administration has been trying to accelerate shipments of Covid-19 vaccines to US states.

Last month, the Biden administration said it was exploring ways to increase manufacturing of J&J's vaccine, as the expected levels of early doses were less than it hoped at the time.

J&J said it has met its commitment to deliver more than 20 million doses of its single-shot vaccine by the end of March in the United States.

In addition to contracting with Emergent BioSolutions to produce the vaccine drug substance, J&J tapped Catalent Inc to handle the final stage - called fill and finish.

Johnson & Johnson faced some manufacturing issues earlier in the year.

A European Union official in early March told Reuters that Johnson & Johnson told the bloc that it was facing supply issues that might complicate plans to deliver 55 million doses of its Covid-19 vaccine in the second quarter of the year.

Emergent, which is a manufacturing partner to both J&J and AstraZeneca, referred to J&J's statement when contacted for comment.

AstraZeneca, whose vaccine is not yet authorized in the US, said: "We are aware of the reports regarding the facility, and we understand Emergent is investigating the matter."

51
Facebook 51
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail